ResMed | RMD - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Ansell USD 274.8M 7.6M 2025-12
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.88M 319K 2026-09
Baxter International USD 730M 5M 2026-09
Cochlear AUD 449.4M 214.45M 2025-12
Cooper Companies USD 401.3M 274.9M 2026-06
CSL USD 1.23B 498M 2025-12
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Fisher Paykel Healthcare NZD 312.7M 27.2M 2026-06
Globus Medical USD 288.47M 1.65M 2026-09
Haemonetics USD 118.36M 580K 2026-09
Idexx Laboratories USD 293.13M 5.04M 2026-09
Inogen USD 43.77M 510K 2024-06
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
Medtronic 3.2B 141M 2026-06
Philips EUR 1.17B 33M 2026-09
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 290.65M 10.86M 2026-06
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Steris USD 366M 3.7M 2026-09
Teleflex USD 220.72M 7.21M 2026-09
Thermo Fisher Scientific USD 1.86B 46M 2026-09